Observational study on the biology of COVID-19 in Saarland
Official title: CORONA in the Saarland
Run by Universität des Saarlandes · NCT04837755 · Data updated 2026-11-12
This study looks at how COVID-19 affects people in different ways, including those with long-term symptoms, to learn more about the disease and its progression.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 0 Years to 110 Years |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Universität des Saarlandes Academic / other |
| Locations | 1 site (Homburg, Saarland) |
| Status | Recruiting |
| Started | March 1, 2020 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | May 25, 2025 |
| Trial ID | NCT04837755 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with any form of COVID-19, including those suffering from long-COVID-19.
✕Probably not a fit
Patients who do not have COVID-19 or long-COVID-19 will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The CORSAAR study is an observational, prospective investigation aimed at understanding the natural biology of COVID-19. It includes patients with various forms of COVID-19, including those experiencing long-COVID-19, and collects comprehensive medical histories, measurements, and biomarkers at baseline, during hospitalization, and after discharge. The study focuses on cytokine measurements to gain insights into the disease's progression and effects.
Why it matters
Potential benefit: If successful, this study could enhance understanding of COVID-19 and inform better treatment strategies for patients.
How similar studies have gone: Other observational studies on COVID-19 have shown success in understanding the disease, making this approach relevant and potentially impactful.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: all form of COVID-19 including long-COVID-19 Exclusion Criteria: \-
Where it's running
-
Saarland University
Homburg, Saarland, Germany Recruiting
Study contacts
- Study coordinator: Robert Bals, MD PhD
- Email: robert.bals@uks.eu
- Phone: +4968411615051
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Investigating olfactory dysfunction after COVID-19 infection
This study is trying to understand why some people still have trouble smelling after recovering from COVID-19 by looking at samples from their noses.
-
Registry to evaluate pregnancy outcomes in women treated for COVID-19
This study is trying to see how treatments for COVID-19, like certain medications, affect the health of pregnant women and their babies.
-
Collecting COVID-19 virus secretions and serum for developing treatments
This study is collecting samples from people with COVID-19 to learn more about how the virus behaves and how it affects recovery, with the goal of improving treatments for those at higher risk.
-
Using donor-derived T cells to treat mild to moderate COVID-19
This study is testing whether T cells from family members who have recovered from COVID-19 can help treat hospitalized patients with mild to moderate COVID-19.
-
Imaging immune activation in COVID-19 patients
This study is testing a special imaging technique to see how the immune system is working in people who have recently recovered from COVID-19.
-
AGILE: an early-phase platform testing treatments for COVID-19
This project tests several experimental antiviral and immune therapies to see if they are safe and work for adults with confirmed COVID-19.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.